enVVeno Medical (NVNO)
(Delayed Data from NSDQ)
$4.64 USD
-0.10 (-2.11%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $4.59 -0.05 (-1.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
enVVeno Medical Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Instruments industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NVNO 4.64 -0.10(-2.11%)
Will NVNO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVNO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVNO
NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain
NVNO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NVNO
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective ...
enVVeno Medical announces findings from health economic study of VenoValve
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency
enVVeno Medical (NVNO) Eyes Future with VenoValve Approval
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to ...